Country Resources for Neurological Disorders 2004 : Results of a Collaborative Study of the World Health Organization and the World Federation of Neurology
Country Resources for Neurological Disorders 2004 : Results of a Collaborative Study of the World Health Organization and the World Federation of Neurology
Neurological disorders, such as strokes, multiple sclerosis, epilepsy, dementia and Parkinson's disease, constitute a large and increasing share of the global burden of disease. This WHO publication brings together a wide range of information on neurological resources across 109 countries, with the participation of leading experts in neurology. The information is arranged under 15 broad themes and topics covered include: common neurological conditions and services in primary care and specialist settings; therapeutic drugs and services; number and types of health professionals; postgraduate teaching; financing issues and disability benefits; and the advocacy role of national associations and non-governmental organisations. The report highlights the fact that the available resources for neurological services in most countries are insufficient compared with the global need for neurological care; as well as the significant inequalities in resources across regions and income groups within countries.
Provides clinical descriptions diagnostic guidelines and codes for all mental and behavioural disorders commonly encountered in clinical psychiatry. The book was developed from chapter V of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10). The clinical descriptions and diagnostic guidelines were finalized after field testing by over 700 clinicians and researchers in 110 institutes in 40 countries making this book the product of the largest ever research effort designed to improve psychiatric diagnosis. Every effort has been made to define categories whose existence is scientifically justifiable as well as clinically useful. The classification divides disorders into ten groups according to major common themes or descriptive likeness a new feature which makes for increased convenience of use. For each disorder the book provides a full description of the main clinical features and all other important but less specific associated features. Diagnostic guidelines indicate the number balance and duration of symptoms usually required before a confident diagnosis can be made. Inclusion and exclusion criteria are also provided together with conditions to be considered in differential diagnosis. The guidelines are worded so that a degree of flexibility is retained for diagnostic decisions in clinical work particularly in the situation where provisional diagnosis may have to be made before the clinical picture is entirely clear or information is complete. ... As befitting a publication of considerable influence the amount of work that went into preparing ICD-10 has been formidable... - The International Journal of Social Psychiatry
Meningitis is deadly and debilitating; it strikes quickly, has serious health, economic and social consequences, and affects people of all ages in all countries of the world. Defeating Meningitis by 2030 – A Global Road Map sets out a plan to tackle the main causes of acute bacterial meningitis. This innovative initiative addresses meningitis not only as an infectious disease that can often be prevented and treated, but also with the absolute need for support and care for people living with disabling sequelae after an episode of meningitis. To defeat meningitis resources are required at all levels. The financing needs to implement the road map have been calculated and categorized to maximize the effect of every dollar invested. Investing in meningitis, will prevent cases of disease, cases of long-lasting sequelae and save lives. Strong multidisciplinary collaborations allowed the road map design to be one that will generate impact beyond meningitis, particularly by combining efforts with other health initiatives at local, national, regional and global levels. Investments called for in this document will strengthen primary health care systems including diagnosis, treatment and care – acting as a powerful lever for recognizing disability and improving access to support and rehabilitation – and providing benefits far beyond meningitis. All 194 WHO Member States have committed to defeating meningitis by 2030. Now investment is needed to not only reduce the avoidable pain and suffering caused by meningitis but to enable better health outcomes beyond meningitis.
Gives specialists in the clinical neurosciences a detailed and authoritative instrument for coding virtually all recognized neurological conditions. Both neurological diseases and neurological manifestations of general diseases and injuries are included in this comprehensive coding tool. The volume is part of a growing family of specialty-based adaptations of ICD-10 which retain the core codes of the parent classification while providing extended detail at the fifth character and beyond. Now in its second edition ICD-NA has been revised to reflect current clinical concepts in the neurosciences as well as the new coding system introduced with ICD-10. The classification was finalized following extensive consultation with numerous professional organizations and international experts thus ensuring the representation of as many viewpoints as are practical and consistent. While remaining directly compatible with ICD-10 ICD-NA offers clinicians and researchers much greater precision allowing them to match an explicit diagnosis with a detailed code at the five- six or seven-character level. In addition a comprehensive alphabetical index and the extensive use of inclusion and exclusion terms provide considerable assistance in finding the correct category for any condition diagnosed. Apart from these opportunities for recording greater diagnostic detail the direct compatibility with ICD-10 facilitates comparisons between statistics compiled according to ICD-NA and national morbidity and mortality statistics compiled according to ICD-10. These features enhance the flexibility of ICD-NA making it suitable for use in morbidity statistics hospital record indexing and epidemiological research by government and other health agencies collecting statistical data under relatively few main headings or by individual physicians and researchers requiring a convenient tool for indexing their clinical and teaching material in sufficient detail. The revised classification should also facilitate the collection of epidemiological data comparisons of the prevalence of individual neurological diseases and identification of the risk factors for these diseases at both national and international levels. In addition to the detailed tabular list of neurological and related disorders the volume includes an explanation of the basic principles of classification and instructions for coding morphology codes for neoplasms relevant to neurology and neurosurgery and a 90-page index of diagnostic terms given in standard or official nomenclatures together with synonyms and eponyms.
The 3rd Global Rehabilitation 2030 meeting was held at WHO headquarters on 10 and 11 July 2023. Since the Rehabilitation 2030: Call for action was launched in 2017, the rehabilitation sector has made significant progress. Over the past 6 years, rehabilitation stakeholders together with WHO have provided technical support to Member States and developed a series of normative guidance and tools that support strengthening rehabilitation in health systems. The 3rd Global Rehabilitation 2030 meeting was an opportunity to review progress of the Rehabilitation 2030 Call for Action so far, as well as to prepare for and coordinate the actions requested in the recent WHA76.6 resolution "Strengthening rehabilitation in health systems" adopted in May 2023. This report summarizes the key discussions, decisions and action points from the meeting.
Although there are several gaps in understanding the many issues related to neurological disorders, we know enough to be able to shape effective policy responses to some of the most common. This book describes and discusses the increasing public health impact of common neurological disorders such as dementia, epilepsy, headache disorders, multiple sclerosis, neuroinfections, neurological disorders associated with malnutrition, pain associated with neurological disorders, Parkinson's disease, stroke and traumatic brain injuries. It provides information and advice on public health interventions that may reduce their occurrence and consequences, and offers health professionals and planners the opportunity to assess the burden caused by these disorders. The clear message that emerges is that unless immediate action is taken globally, the neurological burden is likely to become an increasingly serious and unmanageable.
Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus vector-based vaccines (AstraZeneca COVID-19 ChAdOx-1 vaccine and Johnson & Johnson (J&J) Janssen COVID-19 Ad26.COV2-S vaccine). TTS is a serious and life-threatening adverse event. WHO has issued this interim emergency guidance to increase awareness about TTS in the context of COVID-19 vaccination and help healthcare providers in the assessment and management of potential TTS cases. Knowledge about TTS following vaccination with a COVID-19 adenovirus vector-based vaccine is rapidly evolving. WHO will continue to monitor the situation closely for any changes that may affect this interim guidance and will update the guidance as needed.
Taenia solium is a zoonotic tapeworm which causes taeniasis and cysticercosis in humans. The total number of people with symptomatic or asymptomatic neurocysticercosis is estimated to be 2.56-8.30 million from the data available. Incongruity among studies, however, demonstrates the extent to which neurocysticercosis remains an understudied, misunderstood, neglected tropical disease.
This joint publication by the WHO and the World Psychiatric Association sets out information on psychiatric training and education programmes around the world, based on a questionnaire and other information sources. Topics covered include: training programmes and infrastructure; curricula and teaching methods; evaluation; specialisation and bilateral arrangement; continuing education; licensing and the role of national institutions. It also includes a comparative case study of psychiatric education and training in a high income (Switzerland) and a low income country (Uganda).
Country Resources for Neurological Disorders 2004 : Results of a Collaborative Study of the World Health Organization and the World Federation of Neurology
Country Resources for Neurological Disorders 2004 : Results of a Collaborative Study of the World Health Organization and the World Federation of Neurology
Neurological disorders, such as strokes, multiple sclerosis, epilepsy, dementia and Parkinson's disease, constitute a large and increasing share of the global burden of disease. This WHO publication brings together a wide range of information on neurological resources across 109 countries, with the participation of leading experts in neurology. The information is arranged under 15 broad themes and topics covered include: common neurological conditions and services in primary care and specialist settings; therapeutic drugs and services; number and types of health professionals; postgraduate teaching; financing issues and disability benefits; and the advocacy role of national associations and non-governmental organisations. The report highlights the fact that the available resources for neurological services in most countries are insufficient compared with the global need for neurological care; as well as the significant inequalities in resources across regions and income groups within countries.
The Global status report on alcohol and health and treatment of substance use disorders presents a comprehensive overview of alcohol consumption, alcohol-related harm and policy responses as well as treatment capacities for alcohol and drug use disorders worldwide. The report is based on data collected by WHO from Member States and organized in accordance with the Sustainable Development Goals health target 3.5 which calls on countries to strengthen “the prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol”. The chapter on alcohol and health continues the series of WHO global status reports on alcohol and health and presents the latest available data on the status of, and trends in, alcohol consumption, as well as estimates of the alcohol-attributable disease burden and descriptions of policy responses worldwide. On the basis of data collected from countries on the treatment of substance use disorders the report describes the status of key components of treatment responses to alcohol and drug use disorders and proposes a new service capacity index for these disorders as an additional contextual indicator for monitoring progress in this domain of SDG health target 3.5. The report concludes with broad directions for international action to accelerate progress towards achievement of SDG health target 3.5.
report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children)
report of the WHO Expert Committee on Selection and Use of Essential Medicines, 2023 (including the 23rd WHO Model List of Essential Medicines and the 9th WHO Model List of Essential Medicines for Children)
The 24th meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was held in Geneva, Switzerland, from 24 to 28 April 2023. The Committee considered 85 applications proposing additions, changes and deletions of medicines, medicine classes and formulations on the Model Lists of Essential Medicines. The Committee evaluated the scientific evidence for effectiveness, safety and cost- effectiveness of the medicines in question. The Committee also considered a review of the age-appropriateness of formulations of essential medicines for children, the AWaRe classification of antibiotics, and other matters relevant to the selection and use of essential medicines.
This publication highlights key issues and principles to be considered in the drafting, adoption and implementation of mental health legislation and best practice in mental health services. It contains examples of diverse experiences and practices, as well as extracts of laws and other legal documents from a range of different countries, and a checklist of key policy components. Three main elements of effective mental health legislation are identified, relating to context, content and process.
This will help us customize your experience to showcase the most relevant content to your age group
Please select from below
Login
Not registered?
Sign up
Already registered?
Success – Your message will goes here
We'd love to hear from you!
Thank you for visiting our website. Would you like to provide feedback on how we could improve your experience?
This site does not use any third party cookies with one exception — it uses cookies from Google to deliver its services and to analyze traffic.Learn More.